These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7889237)

  • 1. Is there any indication for an intracardiac defibrillator for the treatment of atrial fibrillation?
    Lévy S; Richard P
    J Cardiovasc Electrophysiol; 1994 Nov; 5(11):982-5. PubMed ID: 7889237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Atrial defibrillator].
    Jung W; Lüderitz B
    Herz; 1998 Jun; 23(4):251-9. PubMed ID: 9690112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrial defibrillator].
    Jung W; Lüderitz B
    Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internal defibrillation: where we have been and where we should be going?
    Lévy S
    J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():61-6. PubMed ID: 16133857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable atrial defibrillators.
    Hillsley RE; Wharton JM
    J Cardiovasc Electrophysiol; 1995 Aug; 6(8):634-48. PubMed ID: 8535562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results.
    Lévy S; Ricard P; Gueunoun M; Yapo F; Trigano J; Mansouri C; Paganelli F
    Circulation; 1997 Jul; 96(1):253-9. PubMed ID: 9236442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of atrial fibrillation detection and use of a preceding synchronization interval as a criterion for shock delivery in humans with atrial fibrillation.
    Sra JS; Maglio C; Dhala A; Blanck Z; Biehl M; Deshpande S; Keelan ET; Jazayeri MR; Akhtar M
    J Am Coll Cardiol; 1996 Nov; 28(6):1532-8. PubMed ID: 8917268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal cardioversion of atrial fibrillation in sheep.
    Cooper RA; Alferness CA; Smith WM; Ideker RE
    Circulation; 1993 May; 87(5):1673-86. PubMed ID: 8491023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial clinical experience with an implantable human atrial defibrillator.
    Lau CP; Tse HF; Lok NS; Lee KL; Ho DS; Sopher M; Murgatroyd F; Camm AJ
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):220-5. PubMed ID: 9121994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation.
    Lévy S; Ricard P; Lau CP; Lok NS; Camm AJ; Murgatroyd FD; Jordaens LJ; Kappenberger LJ; Brugada P; Ripley KL
    J Am Coll Cardiol; 1997 Mar; 29(4):750-5. PubMed ID: 9091520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial defibrillation. New frontiers.
    Carlson MD; Biblo LA
    Cardiol Clin; 1996 Nov; 14(4):607-22. PubMed ID: 8950061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low energy conversion of atrial fibrillation in the sheep.
    Powell AC; Garan H; McGovern BA; Fallon JT; Krishnan SC; Ruskin JN
    J Am Coll Cardiol; 1992 Sep; 20(3):707-11. PubMed ID: 1512352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation.
    Ayers GM; Alferness CA; Ilina M; Wagner DO; Sirokman WA; Adams JM; Griffin JC
    Circulation; 1994 Jan; 89(1):413-22. PubMed ID: 8281677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias.
    Boriani G; Wollmann C; Biffi M; Kühl M; Schuchert A; Sperzel J; Stiller S; Gasparini G; Böcker D
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):461-5. PubMed ID: 12687868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of electrode design, lead configuration and impedance for successful low energy transcatheter atrial defibrillation in dogs.
    Kalman JM; Power JM; Chen JM; Farish SJ; Tonkin AM
    J Am Coll Cardiol; 1993 Oct; 22(4):1199-206. PubMed ID: 8409061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel passive implantable atrial defibrillator using transcutaneous radiofrequency energy transmission successfully cardioverts atrial fibrillation.
    Manoharan G; Evans N; Kidwai B; Allen D; Anderson J; Adgey J
    Circulation; 2003 Sep; 108(11):1382-8. PubMed ID: 12939215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electric treatment of atrial fibrillation].
    Almendral J; Villacastín J; Arenal A; Ortiz M; Morris R; Castellanos E; López-Palop R; Luis Delcán J
    Rev Esp Cardiol; 1996; 49 Suppl 2():50-4. PubMed ID: 8755696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardioversion of atrial fibrillation with low energy internal electric shock].
    Ricard P; Socas AG; Taramasco V; Guenoun M; Lévy S
    Arch Mal Coeur Vaiss; 1997 Dec; 90(12):1605-10. PubMed ID: 9587440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of transvenous low energy cardioversion of atrial fibrillation in patients with a history of ventricular tachycardia: effects of rate and repolarization time on proarrhythmic risk.
    Simons GR; Newby KH; Kearney MM; Brandon MJ; Natale A
    Pacing Clin Electrophysiol; 1998 Feb; 21(2):430-7. PubMed ID: 9507545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of atrial refractoriness to upper and lower limits of vulnerability for atrial fibrillation/flutter following implantable ventricular defibrillator shocks.
    Katz A; Sweeney RJ; Gill RM; Reid PR; Prystowsky EN
    Circulation; 1999 Sep; 100(10):1125-30. PubMed ID: 10477539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.